The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles

References

• Agarwal R, Katare OP, Vyas SP. 2001. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 228:43–52.
   PubMed Web of Science ®Google Scholar
• Ahad A, Al-Mohizea AM, Al-Jenoobi FI, Aqil M. 2014a. Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension. Drug Deliv, Posted online on July. 28:1–12.
   Google Scholar
• Ahad A, Aqil M, Ali A. 2014b. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole. Int J Biol Macromol. 64:144–149.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Chaudhary H, Sultana Y, Mujeeb M, Talegaonkar S. 2009. Chemical penetration enhancers: a patent review. Expert Opin Ther Pat. 19:969–988.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. 2013. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm. 443:26–38.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. 2014c. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: Preclinical assessment of pharmacokinetic in wistar albino rats. Expert Opin Drug Deliv. 11:1149–1162.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2010. Transdermal drug delivery: the inherent challenges and technological advancements. Asian J Pharm Sci. 5:276–288.
   Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2011a. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Deliv. 8:213–224.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2011b. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm. 37:583–596.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2012. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine. 8:237–249.
   PubMed Web of Science ®Google Scholar
• Ahad A, Raish M, Al-Mohizea AM, Al-Jenoobi FI, Alam MA. 2014d. Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel. Int J Biol Macromol. 67:99–104.
   PubMed Web of Science ®Google Scholar
• Alexander A, Dwivedi S, Ajazuddin, Giri TK, Saraf S, Tripathi DK. 2012. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release. 164:26–40.
   PubMed Web of Science ®Google Scholar
• Aqil M, Ahad A, Sultana Y, Ali A. 2007. Status of terpenes as skin penetration enhancers. Drug Discov Today. 12:1061–1067.
   PubMed Web of Science ®Google Scholar
• Aqil M, Ali A, Sultana Y, Parvez N. 2004. Communication: Matrix type transdermal drug delivery systems of metoprolol tartrate: skin toxicity and in vivo characterization. Ethiop Pharm J. 22:53–60.
   Google Scholar
• Bachhav YG, Patravale VB. 2009. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm. 365:175–179.
   PubMed Web of Science ®Google Scholar
• Bendas ER, Tadros MI. 2007. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech. 8:E107.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. 1992. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1104:226–232.
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D. 2003. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys J. 84:1010–1024.
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G. 1998. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1368: 201–215.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Kohli K, Amin S, Rathee P, Kumar V. 2011. Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design. J Pharm Sci. 100:580–593.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Rohilla A, Rathee P, Kumar V. 2013. Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers. Int J Biol Macromol. 55:246–253.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13:123–133.
   PubMed Web of Science ®Google Scholar
• Dave V, Kumar D, Lewis S, Paliwal S. 2010. Ethosome for Enhanced Transdermal Drug Delivery of Aceclofenac. Int J Drug Deliv. 2: 81–92.
   Google Scholar
• Draize JH, Woodard G, Calvery HO. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 82:377–390.
   Web of Science ®Google Scholar
• Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. 2013. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers. AAPS PharmSciTech. 14:133–140.
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 397: 164–172.
   PubMed Web of Science ®Google Scholar
• Elsabahy M, Foldvari M. 2013. Needle-free gene delivery through the skin: an overview of recent strategies. Curr Pharm Des. 19:7301–7315.
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. 2006. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 322:60–66.
   PubMed Web of Science ®Google Scholar
• Garg AK, Mohan NL, Meenakshi C. 2010. Gel containing ethosomal vesicles for transdermal delivery of aceclofenac. Int J Pharmacy Pharm Sci. 2:102–108.
   Google Scholar
• Glavas-dodov M, Fredro-kumbaradzi E, Goracinova K, Calis S, Simonoska M, Hincal AA. 2003. 5-Fluorouracil in topical liposome gels for anticancer treatment -Formulation and evaluation. Acta Pharmacol Sin. 53:241–245.
   Google Scholar
• Gupta A, Aggarwal G, Singla S, Arora R. 2012. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization, and performance evaluation. Sci Pharm. 80:1061–1080.
   PubMedGoogle Scholar
• Higuchi T. 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Hiruta Y, Hattori Y, Kawano K, Obata Y, Maitani Y. 2006. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release. 113:146–154.
   PubMed Web of Science ®Google Scholar
• Jain R, Aqil M, Ahad A, Ali A, Khar RK. 2008. Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. Drug Dev Ind Pharm. 34:384–389.
   PubMed Web of Science ®Google Scholar
• Kim MS, Baek IH. 2014. Fabrication and evaluation of valsartan-polymer- surfactant composite nanoparticles by using the supercritical antisolvent process. Int J Nanomedicine. 9:5167–5176.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. 1983. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 15:25–35.
   Web of Science ®Google Scholar
• Moghimi HR, Makhmalzadeh BS, Manafi A. 2009. Enhancement effect of terpenes on silver sulphadiazine permeation through third-degree burn eschar. Burns. 35:1165–1170.
   PubMed Web of Science ®Google Scholar
• Mura S, Manconi M, Fadda AM, Sala MC, Perricci J, Pini E, Sinico C. 2013. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy. Pharm Dev Technol. 18:1339–1345.
   PubMed Web of Science ®Google Scholar
• Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. 2009. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 380:72–79.
   PubMed Web of Science ®Google Scholar
• Nishida N, Taniyama K, Sawabe T, Manome Y. 2010. Development and evaluation of a monolithic drug-in-adhesive patch for valsartan. Int J Pharm. 402:103–109.
   PubMed Web of Science ®Google Scholar
• Paget GM, Barnes JM. 1964. Interspecies dosage conversion scheme in evaluation of results and quantitative application in different species. In: Laurence DR, Bacharach AL, Eds. Evaluation of Drug Activities: Pharmacometrics. London and New York: Academic press. pp. 160–162.
   Google Scholar
• Patel SS, Patel MS, Salampure S, Vishwanath B, Patel NM. 2010. Development and evaluation of liposomes for topical delivery of tacrolimus (Fk-506). J Sci Res. 2:585–596.
   Google Scholar
• Peppas NA. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 60:110–111.
   PubMedGoogle Scholar
• Piao ZZ, Lee ES, Tran HT, Lee BJ. 2008. Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection. Arch Pharm Res. 31:1055–1059.
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. 1987. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 5:23–36.
   Google Scholar
• Rizwan M, Aqil M, Ahad A, Sultana Y, Ali MM. 2008. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev Ind Pharm. 34:618–626.
   PubMed Web of Science ®Google Scholar
• Tatar S, Saglik S. 2002. Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. J Pharm Biomed Anal. 30:371–375.
   PubMed Web of Science ®Google Scholar
• Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK. 2007. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech. 8:2.
   PubMed Web of Science ®Google Scholar